KIT and neoplasm: A case report of a canine with metastatic oral melanoma carrying an exon 11 mutation in KIT that was treated with toceranib reported initial improvement of tumour-associated clinical signs and reduced size of the tumour and metastatic lymph node; however, therapy was terminated on day 43 due to disease progression, and the dog died on day 54 [96].